Concepedia

Author

Thomas Zwingers

Ludwig-Maximilians-Universität München

Also Known As

Krisztian Lato, T Zwingers, Thomas ZWINGERS, Thomas Zwingers

45

Publications

2.9K

Citations

18

H-Index

52

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenHeinrich Heine University DüsseldorfKonrad-Adenauer-StiftungUniversity Hospital AugsburgUniversity of Liverpool
TZ

About

Thomas Zwingers is an author at Ludwig-Maximilians-Universität München specializing in medicine, immunology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

1.3K

2

Health Sciences

2

2

60

3

Clinical Nutrition

2

2

60

4

Cell Biology

1

1

45

5

Endocrinology

1

1

21

Thomas Zwingers

×

23

Publications

2.8K

Citations

18

H-Index

YearCitations

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

Hans‐Peter Hartung, R Gonsette, Nikolaus König,

The Lancet

2002

941

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Brigitte Rack, Christian Schindlbeck, Julia Jückstöck,

JNCI Journal of the National Cancer Institute

2014

601

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

A. Herrmann, Eva Hoster, Thomas Zwingers,

Journal of Clinical Oncology

2008

394

Systemic isotretinoin in the treatment of rosacea – doxycycline‐ and placebo‐controlled, randomized clinical study

Harald Gollnick, Ulrike Blume‐Peytavi, Eörs Lāszlō Szabó,

JDDG Journal der Deutschen Dermatologischen Gesellschaft

2010

117

Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.

Brigitte Rack, Julia Jückstöck, Eva-Maria Genss,

PubMed

2010

108

Gilbert's Syndrome and Irinotecan Toxicity: Combination with UDP-Glucuronosyltransferase 1A7 Variants Increases Risk

Tim O. Lankisch, Christoph Schulz, Thomas Zwingers,

Cancer Epidemiology Biomarkers & Prevention

2008

91

Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases

Ulrich Dührsen, W. Augener, Thomas Zwingers,

British Journal of Haematology

1987

87

Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma. Kiel-Wien-Lymphoma Study Group.

Brigitte Schlegelberger, Thomas Zwingers, Lana Harder,

PubMed

1999

76

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

Ludwig Fischer von Weikersthal, Andreas Schalhorn, Martina Stauch,

European Journal of Cancer

2010

59

UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer

Christoph Schulz, Volker Heinemann, Andreas Schalhorn,

World Journal of Gastroenterology

2009

49

Page 1